• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因治疗和干细胞生物学中的插入诱变

Insertional mutagenesis in gene therapy and stem cell biology.

作者信息

Baum Christopher

机构信息

Department of Experimental Hematology, Hannover Medical School, Hannover, Germany.

出版信息

Curr Opin Hematol. 2007 Jul;14(4):337-42. doi: 10.1097/MOH.0b013e3281900f01.

DOI:10.1097/MOH.0b013e3281900f01
PMID:17534158
Abstract

PURPOSE OF REVIEW

Recent preclinical and clinical studies revealed that the semirandom insertion of transgenes into chromosomal DNA of hematopoietic cells may induce clonal competition, which potentially may even trigger leukemia or sarcoma. Insertional mutagenesis caused by gene vectors has thus led to major uncertainty among those developing advanced hematopoietic cell therapies. This review summarizes novel studies of underlying mechanisms; these studies have demonstrated the possibility of improved gene vector biosafety and generated new insights into stem cell biology.

RECENT FINDINGS

The characteristic insertion pattern of various retroviral gene vector systems may be explained by properties of the viral integrase and associated cellular cofactors. Cell culture assays and animal models, including disease-specific and cancer-prone mouse models, are emerging that reveal the contributions of vector features and systemic factors to induction of clonal imbalance. Databases summarizing vector insertion sites in dominant hematopoietic clones are evolving as new tools to identify genes that regulate clonal homeostasis.

SUMMARY

Mechanistic studies of insertional mutagenesis by random gene vector insertion will lead to improved tools for advanced hematopoietic cell therapy. Simultaneously, fascinating insights into gene networks that regulate cell fitness will be generated, with important consequences for the fields of hematology, oncology and regenerative medicine.

摘要

综述目的

近期的临床前和临床研究表明,转基因在造血细胞染色体DNA中的半随机插入可能引发克隆竞争,甚至有可能引发白血病或肉瘤。因此,基因载体引起的插入诱变在那些开发先进造血细胞疗法的人群中引发了重大的不确定性。本综述总结了关于潜在机制的新研究;这些研究证明了改善基因载体生物安全性的可能性,并对干细胞生物学产生了新的见解。

最新发现

各种逆转录病毒基因载体系统的特征性插入模式可以通过病毒整合酶和相关细胞辅助因子的特性来解释。细胞培养试验和动物模型,包括疾病特异性和易患癌症的小鼠模型,正在不断涌现,揭示了载体特征和全身因素对克隆失衡诱导的作用。总结优势造血克隆中载体插入位点的数据库正在不断发展,成为识别调节克隆稳态基因的新工具。

总结

对随机基因载体插入引起的插入诱变进行机制研究,将为先进的造血细胞治疗带来更好的工具。同时,将对调节细胞适应性的基因网络产生迷人的见解,这将对血液学、肿瘤学和再生医学领域产生重要影响。

相似文献

1
Insertional mutagenesis in gene therapy and stem cell biology.基因治疗和干细胞生物学中的插入诱变
Curr Opin Hematol. 2007 Jul;14(4):337-42. doi: 10.1097/MOH.0b013e3281900f01.
2
Insertional mutagenesis and clonal dominance: biological and statistical considerations.插入诱变与克隆优势:生物学及统计学考量
Gene Ther. 2008 Jan;15(2):143-53. doi: 10.1038/sj.gt.3303052. Epub 2007 Nov 1.
3
Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.整合型基因递送系统诱导的插入诱变与恶性肿瘤发生:对设计更安全的患者基因治疗干预措施的启示
Drug News Perspect. 2009 May;22(4):185-96. doi: 10.1358/dnp.2009.22.4.1367704.
4
Concise review: managing genotoxicity in the therapeutic modification of stem cells.简明综述:干细胞治疗修饰中的遗传毒性管理。
Stem Cells. 2011 Oct;29(10):1479-84. doi: 10.1002/stem.716.
5
Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene.通过编码大T癌基因的复制缺陷型逆转录病毒载体进行插入诱变。
Ann N Y Acad Sci. 2007 Jun;1106:95-113. doi: 10.1196/annals.1392.003. Epub 2007 Mar 29.
6
Retroviral insertion site analysis in dominant haematopoietic clones.优势造血克隆中的逆转录病毒插入位点分析
Methods Mol Biol. 2009;506:373-90. doi: 10.1007/978-1-59745-409-4_25.
7
Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.基因治疗的进展与前景:改进型慢病毒和逆转录病毒载体的发展——设计、生物安全性及生产
Gene Ther. 2005 Jul;12(14):1089-98. doi: 10.1038/sj.gt.3302570.
8
Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells.慢病毒修饰的造血干细胞移植的照射预处理后的小鼠白血病
Eur J Haematol. 2007 Apr;78(4):303-13. doi: 10.1111/j.1600-0609.2006.00813.x.
9
Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.基因转移载体的染色体插入导致的诱变与肿瘤发生
Hum Gene Ther. 2006 Mar;17(3):253-63. doi: 10.1089/hum.2006.17.253.
10
Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy.减毒逆转录病毒载体对V79细胞基因组的逆转录病毒插入突变效应:对基因治疗的启示
Gene Ther. 2003 Sep;10(19):1703-11. doi: 10.1038/sj.gt.3302059.

引用本文的文献

1
One-step induction of human GABAergic neurons promotes presynaptic development & synapse maturation.人γ-氨基丁酸能神经元的一步诱导促进突触前发育和突触成熟。
bioRxiv. 2025 Jul 7:2025.06.30.662293. doi: 10.1101/2025.06.30.662293.
2
AI-driven automated discovery tools reveal diverse behavioral competencies of biological networks.人工智能驱动的自动发现工具揭示了生物网络的多种行为能力。
Elife. 2025 Jan 13;13:RP92683. doi: 10.7554/eLife.92683.
3
Fully defined NGN2 neuron protocol reveals diverse signatures of neuronal maturation.完全定义的 NGN2 神经元方案揭示了神经元成熟的多样化特征。
Cell Rep Methods. 2024 Sep 16;4(9):100858. doi: 10.1016/j.crmeth.2024.100858. Epub 2024 Sep 9.
4
Effectiveness of CAR-T treatment toward the potential risk of second malignancies.嵌合抗原受体T细胞(CAR-T)疗法对继发性恶性肿瘤潜在风险的有效性。
Front Immunol. 2024 May 2;15:1384002. doi: 10.3389/fimmu.2024.1384002. eCollection 2024.
5
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia.造血干细胞基因编辑可挽救 X 连锁无丙种球蛋白血症的 B 细胞发育障碍。
J Allergy Clin Immunol. 2024 Jul;154(1):195-208.e8. doi: 10.1016/j.jaci.2024.03.003. Epub 2024 Mar 11.
6
Urine-derived induced pluripotent/neural stem cells for modeling neurological diseases.用于神经系统疾病建模的尿液来源诱导多能/神经干细胞
Cell Biosci. 2021 May 13;11(1):85. doi: 10.1186/s13578-021-00594-5.
7
Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance.搅拌悬浮生物反应器中基于细胞的治疗产品生产:关于符合cGMP的思考
Front Bioeng Biotechnol. 2020 Nov 26;8:599674. doi: 10.3389/fbioe.2020.599674. eCollection 2020.
8
Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies.诱导多能干细胞:治疗疾病的希望,包括肌肉疾病。
Int J Mol Sci. 2020 Jul 30;21(15):5467. doi: 10.3390/ijms21155467.
9
iPS-Cell Technology and the Problem of Genetic Instability-Can It Ever Be Safe for Clinical Use?诱导多能干细胞技术与基因不稳定问题——它能安全用于临床吗?
J Clin Med. 2019 Feb 28;8(3):288. doi: 10.3390/jcm8030288.
10
Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.通过优化不同病毒载体中的miRNA表达盒来改善miRNA递送
Hum Gene Ther Methods. 2017 Aug;28(4):177-190. doi: 10.1089/hgtb.2017.036.